Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis

被引:26
作者
Shuai, Z. W. [1 ]
Lv, Y. F. [1 ]
Zhang, M. M. [1 ]
Hu, Z. Y. [1 ]
机构
[1] Med Univ Anhui, Dept Rheumatol, Affiliated Hosp 1, Hefei, Peoples R China
关键词
Antineutrophil cytoplasmic antibody; Clinical damage; Antimyeloperoxidase antibody; ANCA-associated vasculitis; Pathogenic mechanism; RHEUMATOLOGY; 1990; CRITERIA; SYSTEMIC VASCULITIDES; ANCA; AUTOANTIBODIES; CLASSIFICATION;
D O I
10.4238/2015.May.18.22
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This prospective study analyzed the clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody (MPOANCA)-associated vasculitis and explored the relationship between MPO-ANCA and clinical manifestations of the associated vasculitis in 132 p-ANCA and MPO-ANCA-positive patients (average age, 62.3 +/- 14.8 years) who were initially diagnosed with ANCA-associated vasculitis. The p-ANCA and MPO-ANCA levels in peripheral blood were detected in all patients. Among these, 128 (97%) had microscopic polyangiitis (MPA), 3 (2.3%) had granulomatous polyangiitis, and 1 (0.7%) had eosinophilic granulomatous vasculitis. The average time of diagnosis was 10.2 +/- 18 months; only 14 (10.6%) patients were diagnosed within 1 month. The main organs involved and the corresponding number of patients were: renal, 95 (72%); lung, 89 (67.4%); joints, 35 (26.5%); heart, 26 (19.7%); peripheral nerve, 23 (17.4%); skin rash, 14 (10.6%); and CNS, 13 (9.8%). Older patients were more likely to show lung involvement in the early disease stage, whereas the joints were involved mostly in the younger patients. The p-ANCA levels (mean titers, 1: 60) were not correlated with disease activity and extent of organ involvement, and the MPO-ANCA levels were positively correlated with disease activity, but had no correlation with the extent of organ involvement. MPO-ANCA vasculitis is a common occurrence in China; it mainly involves the elderly and presents as clinical manifestations of MPA. However, the multiple organ damage is not specific leading to delay in diagnosis. MPO-ANCA may play a pathogenic role in the associated vasculitis, and the diverse clinical manifestations might be related with the different characteristics of MPO-ANCA.
引用
收藏
页码:5296 / 5303
页数:8
相关论文
共 20 条
[1]   Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea [J].
Ahn, Joong Kyong ;
Hwang, Ji-Won ;
Lee, Jaejoon ;
Jeon, Chan Hong ;
Cha, Hoon-Suk ;
Koh, Eun-Mi .
RHEUMATOLOGY INTERNATIONAL, 2012, 32 (10) :2979-2986
[2]   Cinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre [J].
Chen, M ;
Yu, F ;
Zhang, Y ;
Zhao, MH .
POSTGRADUATE MEDICAL JOURNAL, 2005, 81 (961) :723-727
[3]   Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals [J].
Cui, Zhao ;
Zhao, Ming-hui ;
Segelmark, Marten ;
Hellmark, Thomas .
KIDNEY INTERNATIONAL, 2010, 78 (06) :590-597
[4]   Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK [J].
Fujimoto, Shouichi ;
Watts, Richard A. ;
Kobayashi, Shigeto ;
Suzuki, Kazuo ;
Jayne, David R. W. ;
Scott, David G. I. ;
Hashimoto, Hiroshi ;
Nunoi, Hiroyuki .
RHEUMATOLOGY, 2011, 50 (10) :1916-1920
[5]   Serial ANCA titers: Useful tool for prevention of relapses in ANCA-associated vasculitis [J].
Han, WK ;
Choi, HK ;
Roth, RM ;
Mccluskey, RT ;
Niles, JL .
KIDNEY INTERNATIONAL, 2003, 63 (03) :1079-1085
[6]   2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides [J].
Jennette, J. C. ;
Falk, R. J. ;
Bacon, P. A. ;
Basu, N. ;
Cid, M. C. ;
Ferrario, F. ;
Flores-Suarez, L. F. ;
Gross, W. L. ;
Guillevin, L. ;
Hagen, E. C. ;
Hoffman, G. S. ;
Jayne, D. R. ;
Kallenberg, C. G. M. ;
Lamprecht, P. ;
Langford, C. A. ;
Luqmani, R. A. ;
Mahr, A. D. ;
Matteson, E. L. ;
Merkel, P. A. ;
Ozen, S. ;
Pusey, C. D. ;
Rasmussen, N. ;
Rees, A. J. ;
Scott, D. G. I. ;
Specks, U. ;
Stone, J. H. ;
Takahashi, K. ;
Watts, R. A. .
ARTHRITIS AND RHEUMATISM, 2013, 65 (01) :1-11
[7]   Pathogenesis of ANCA-associated vasculitides [J].
Kallenberg, Cees G. M. .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 :I59-I63
[8]   THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY 1990 CRITERIA FOR THE CLASSIFICATION OF WEGENER GRANULOMATOSIS [J].
LEAVITT, RY ;
FAUCI, AS ;
BLOCH, DA ;
MICHEL, BA ;
HUNDER, GG ;
AREND, WP ;
CALABRESE, LH ;
FRIES, JF ;
LIE, JT ;
LIGHTFOOT, RW ;
MASI, AT ;
MCSHANE, DJ ;
MILLS, JA ;
STEVENS, MB ;
WALLACE, SL ;
ZVAIFLER, NJ .
ARTHRITIS AND RHEUMATISM, 1990, 33 (08) :1101-1107
[9]   Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo [J].
Little, MA ;
Smyth, CL ;
Yadav, R ;
Ambrose, L ;
Cook, HT ;
Nourshargh, S ;
Pusey, CD .
BLOOD, 2005, 106 (06) :2050-2058
[10]   Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies [J].
Mahler, M. ;
Radice, A. ;
Yang, W. ;
Bentow, C. ;
Seaman, A. ;
Bianchi, L. ;
Sinico, R. A. .
CLINICA CHIMICA ACTA, 2012, 413 (7-8) :719-726